top of page

Sweet Success Story: How Small Adjustments Restored Balance for Alex

Writer: Haylie Kennedy BSN, RN, CDCES
Haylie Kennedy BSN, RN, CDCES
Nov 2
5 min read

 

When I first connected with Alex*, they were carrying an overwhelming diabetes burden. Managing diabetes is hard enough on a good day, but despite using an advanced automated insulin delivery (AID) system and taking very high daily doses of insulin, Alex’s numbers simply weren't reflecting the effort they were putting in.


When I looked at their baseline CGM data at the start of our journey together, the picture was concerning:

  • Average Glucose: ~350 mg/dL

  • Time in Range (70–180 mg/dL): ~6%

  • Hyperglycemia (>250 mg/dL): Nearly 9 in 10 readings (~87%)

  • Glycemia Risk Index (GRI): 100 (the highest risk level)

  • In-Office A1c: 11.1%


Alex was frustrated, exhausted, and stuck in severe hyperglycemia. As a Clinical Diabetes Specialist, I know that behind numbers like these is often a sign that a patient is missing the personalized guidance, time, and longitudinal support needed to make sense of complex technology.

Over the course of about four months, my colleague Jennifer and I provided nearly five hours (288 minutes) of dedicated clinical support to Alex. Through proactive device data monitoring and five one-on-one sessions over the phone, we walked alongside Alex to build trust, troubleshoot barriers, and make step-by-step adjustments that truly fit their life.

Optimizing the Pump and Building Confidence

My first priority was ensuring Alex’s pump settings were actually working for them, not against them. During our initial reviews, I spotted several straightforward setting optimizations that made an immediate difference:

  • Strengthening the Correction Factor: Shifted from 1:25 to 1:20 to help bring high glucose down more effectively.

  • Updating Pump Parameters: Increased the total daily insulin setting to Tandem’s maximum (200 units), corrected their weight setting, and adjusted the maximum basal limit.

  • Unlocking Sleep Mode: I established an automated nightly Sleep Mode schedule to help stabilize glucose overnight.

Settings are only half the equation, though. I spent time helping Alex understand why Sleep Mode works and gave gentle, practical guidance around mealtime carbohydrate goal.

The early response was incredible. By our next check-in, Alex’s Time in Range jumped from ~6% to 38%. Seeing their overnight numbers level out gave Alex a renewed sense of hope and momentum, all achieved with zero significant hypoglycemia.

As fasting levels stabilized, I shifted focus to daytime spikes, progressively fine-tuning daytime basal rates and strengthening the correction factor further.

Building Consistency and Trust

Beyond setting adjustments, a major turning point in Alex’s journey was consistent device wear. At the start, text reminders helped them stay on track with wearing their pump and CGM daily. Over time, knowing our team was regularly monitoring their data gave them the confidence and reassurance to maintain continuous wear on their own.

Nurturing Habits Around Nutrition

As I continued reviewing CGM patterns together with Alex, it became clear that insulin settings were only part of the story. Alex’s reported carbohydrate intake remained quite high, sometimes averaging over 250 grams a day, with single meals containing 60–100 grams.

Rather than giving rigid rules, I conducted thoughtful dietary reviews and offered practical, individualized strategies. I talked about portion sizes, balancing carbs with protein, and making simple, satisfying substitutions.

When Alex candidly shared that counting carbs felt confusing and hard to estimate accurately, I introduced easy-to-use carb-counting apps, shared visual educational guides, and kept reinforcing doable meal targets.

By Month 2 (late July), Alex’s Time in Range reached 52%, average glucose dropped to 189 mg/dL, and their Glycemia Risk Index was cut in half, dropping from 100 to 51.

Uncovering the Hidden Barriers

One of the greatest benefits of ongoing, regular contact is that it creates a safe space for honesty. As our relationship grew, Alex opened up about behaviors to both Jennifer and me that a CGM report alone could never explain.

They admitted to occasionally delaying or skipping premeal boluses, and at times, entering "fake" carbohydrates into the pump just to trigger a correction dose when glucose felt stuck high.

Jennifer used this as a teachable moment. She walked through how automated pump algorithms interpret data and explained premeal timing, insulin duration, stacking risks, and how Control-IQ responds. Together, they adjusted the active insulin duration setting from 5 hours to 3 hours, and Jennifer stayed on the phone with Alex to make sure the change was saved correctly and the algorithm was reactivated.

Jennifer also discussed additional options for managing persistent insulin resistance. After educating Alex on GLP-1/GIP therapy, their provider prescribed the medication. When Alex needed surgery shortly after starting, Jennifer was right there to support them through holding and safely restarting the dose, while continuing to reinforce premeal bolusing habits.

Where Alex Is Today: About Four Months Later

The longitudinal progress Alex achieved over four months has been nothing short of transformative:

  • Time in Range (70–180 mg/dL): Soared from ~6% at baseline to 83% (a 77 percentage point increase).

  • Average Glucose & GMI: Dropped by 200 mg/dL, moving from ~350 mg/dL down to ~150 mg/dL (with a current GMI of 6.9%).

  • Hyperglycemia (>250 mg/dL): Decreased from nearly 9 in 10 readings (~87%) down to just 2%.

  • Glycemia Risk Index (GRI): Cut by 85 points, plummeting from a maximum risk score of 100 down to 15.

  • Total Daily Insulin: Reduced by approximately 25%, significantly decreasing their daily insulin burden.

  • Time Below Range (<70 mg/dL): Maintained at 0.1%, achieving dramatic glucose stability with virtually zero hypoglycemia.

  • Laboratory A1c: Dropped 3.7 percentage points, improving from 11.1% down to 7.4%.

*Note: Patient name, dates, and select metrics have been anonymized or rounded for clinical summary presentation.

The Power of Touch + Technology

Alex’s journey shows what is possible when advanced diabetes technology is paired with continuous, human-centered care. Single clinic visits every few months simply aren't enough to tackle complex behavioral, nutritional, and algorithmic challenges.


Alex moved from severe, high-risk hyperglycemia to a thriving 83% Time in Range, an A1c of 7.4%, and a 25% reduction in daily insulin needs, all while keeping hypoglycemia virtually at zero. That is the power of keeping clinical educators in the loop: empowering people with diabetes, one touchpoint at a time.

Interested in exploring how a centralized platform or clinical support partnership could work for your practice? eeach out directly at jhughes@aegisdigitalhealth.com to schedule a tailored workflow consultation or request our clinical coding guides.


-------

SweetSpot partners with endocrinology practices to provide virtual CGM monitoring and enhanced patient care.


SweetSpot combines a centralized software platform for managing diabetes device data, such as data from CGMs and insulin pumps, with wrap-around clinical support services. SweetSpot’s virtual team of Certified Diabetes Care and Education Specialists (CDCES) performs monthly CGM data reviews and coordinates with providers and patients to facilitate treatment plan changes. By actively managing and remotely reviewing CGM data between patient visits, we ensure patients receive timely treatment adjustments to improve glycemic control and patient outcomes.


Additionally, SweetSpot’s automated capture of reimbursable care events optimizes CPT code utilization, unlocking new revenue streams for practices and making our partnerships both clinically effective and financially profitable.

 
 
 

Comments


bottom of page